{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:26:40Z","timestamp":1790627200673,"version":"4.1.0"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec><jats:title>Background and objectives<\/jats:title><jats:p>Human hepatitis E virus (<jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>) is prevalent worldwide. Iatrogenic <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content> has recently been identified based on the reports of transfusion\u2010transmitted cases. The detection rate of <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> and seroprevalence of <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010IgG\/IgM have been regionally evaluated in Japan, and donor plasma collected in Hokkaido is currently screened by nucleic acid amplification testing. However, the detection rate of <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> in blood donors in Japan outside of Hokkaido has not been reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A total of 620 140 qualified donor plasma samples from Japanese regions excluding Hokkaido were tested for <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> (pools of 50 or 500) between 2004 and 2014. <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content>\u2010positive plasma bags were identified, and the <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content> viral load, genotype and anti\u2010<jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content> immunoglobulin (Ig)G\/IgM were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The detection rate of <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> (pools of 50) was 1\/15 075 and higher in eastern than in western Japan. All 36 <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content>\u2010positive samples were genotype 3 with viral load ranging from &lt;1\u00b769 to 7\u00b722 log10 copies\/ml.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our detection rate of <jats:styled-content style=\"fixed-case\">HEV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> in donor populations in Japan outside Hokkaido (1\/15 075 donations) is generally lower than reported in Europe and lower than previously reported for Hokkaido (1\/8173 donations). As methods varied, we cannot exclude that these differences are reflective of differing <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> detection limits. In contrast to Hokkaido where genotype 4 has been reported among blood donations, all our positive donations were genotype 3, which is less pathogenic.<\/jats:p><\/jats:sec>","DOI":"10.1111\/vox.12425","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T21:36:25Z","timestamp":1465508185000},"page":"242-246","source":"Crossref","is-referenced-by-count":35,"title":["Hepatitis E virus in donor plasma collected in Japan"],"prefix":"10.1111","volume":"111","author":[{"given":"T.","family":"Minagi","sequence":"first","affiliation":[{"name":"Quality Control Kyoto Plant Japan Blood Products Organization Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Quality Control Kyoto Plant Japan Blood Products Organization Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ikegawa","sequence":"additional","affiliation":[{"name":"Quality Control Kyoto Plant Japan Blood Products Organization Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ideno","sequence":"additional","affiliation":[{"name":"R &amp; D Division Japan Blood Products Organization Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Takahashi","sequence":"additional","affiliation":[{"name":"R &amp; D Division Japan Blood Products Organization Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sakai","sequence":"additional","affiliation":[{"name":"R &amp; D Division Japan Blood Products Organization Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Graduate School of Veterinary Medicine Rakuno Gakuen University Ebetsu Hokkaido Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yunoki","sequence":"additional","affiliation":[{"name":"R &amp; D Division Japan Blood Products Organization Tokyo Japan"},{"name":"Graduate School of Veterinary Medicine Rakuno Gakuen University Ebetsu Hokkaido Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wakisaka","sequence":"additional","affiliation":[{"name":"R &amp; D Division Japan Blood Products Organization Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10104507"},{"key":"e_1_2_7_3_1","first-page":"1021","volume-title":"Hepeviridae","author":"King AMQ","year":"2011"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.482"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02762-12"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06540.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2012.01638.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01722.x"},{"key":"e_1_2_7_9_1","first-page":"1607","article-title":"A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver. Transplant recipients in Japan","volume":"2","author":"Inagaki Y","year":"2015","journal-title":"Bio Med"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12156"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01445.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01554.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01527.x"},{"key":"e_1_2_7_14_1","unstructured":"Steering committee for blood operation in Japan MHLW Japan [in Japanese]: Data downloaded fromhttp:\/\/www.mhlw.go.jp\/file\/05-Shingikai-11121000-Iyakushokuhinkyoku-Soumuka\/0000116893.pdf. [Last accessed 3 June 2016]"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01362.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13355"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12056"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119576"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2824.2011.01512.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12175"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2005.07.004"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.9.3209-3218.2002"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2957\/kanzo.47.384"},{"key":"e_1_2_7_24_1","unstructured":"Reflection paper on viral safety of plasma\u2010derived medicinal products with respect to hepatitis E virus. (EMA\/CHMP\/BWP\/723009\/2014). Available from:http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2015\/07\/WC500189012.pdf. [Last accessed 3 June 2016]"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvox.12425","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.12425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T14:10:00Z","timestamp":1696169400000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.12425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1111\/vox.12425"],"URL":"https:\/\/doi.org\/10.1111\/vox.12425","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}